Gross Profit Summary of SCI Pharmtech, Inc.

SCI Pharmtech, Inc.'s latest annual gross profit in 2023 was 350.32 Million TWD , up 20.31% from previous year.
SCI Pharmtech, Inc.'s latest quarterly gross profit in 2024 Q2 was 100.42 Million TWD , up 9.31% from previous quarter.
SCI Pharmtech, Inc. reported a annual gross profit of 291.17 Million TWD in annual gross profit 2022, up 39.93% from previous year.
SCI Pharmtech, Inc. reported a annual gross profit of 208.08 Million TWD in annual gross profit 2021, down -83.67% from previous year.
SCI Pharmtech, Inc. reported a quarterly gross profit of 91.87 Million TWD for 2024 Q1, up 36.32% from previous quarter.
SCI Pharmtech, Inc. reported a quarterly gross profit of 80.15 Million TWD for 2023 Q3, up 0.49% from previous quarter.

Annual Gross Profit Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Gross Profit of SCI Pharmtech, Inc. (2023 - 2009)

Year	Gross Profit	Gross Profit Growth
2023	350.32 Million TWD	20.31%
2022	291.17 Million TWD	39.93%
2021	208.08 Million TWD	-83.67%
2020	1.27 Billion TWD	36.18%
2019	935.77 Million TWD	24.95%
2018	748.94 Million TWD	89.28%
2017	395.68 Million TWD	-49.95%
2016	790.52 Million TWD	20.68%
2015	655.05 Million TWD	36.65%
2014	479.35 Million TWD	20.75%
2013	396.98 Million TWD	-0.23%
2012	397.88 Million TWD	29.53%
2011	307.18 Million TWD	-6.62%
2010	328.95 Million TWD	-0.73%
2009	331.37 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	100.42 Million TWD	9.31%
2024 Q1	91.87 Million TWD	36.32%
2023 Q3	80.15 Million TWD	0.49%
2023 Q4	67.39 Million TWD	-15.92%
2023 Q1	123.01 Million TWD	48.39%
2023 Q2	79.76 Million TWD	-35.16%
2023 FY	350.32 Million TWD	20.31%
2022 Q2	60.07 Million TWD	8.9%
2022 FY	291.17 Million TWD	39.93%
2022 Q1	55.16 Million TWD	1497.97%
2022 Q4	82.89 Million TWD	-10.91%
2022 Q3	93.04 Million TWD	54.89%
2021 Q1	95.84 Million TWD	-57.59%
2021 Q3	74.2 Million TWD	114.49%
2021 Q2	34.59 Million TWD	-63.91%
2021 FY	208.08 Million TWD	-83.67%
2021 Q4	3.45 Million TWD	-95.35%
2020 FY	1.27 Billion TWD	36.18%
2020 Q2	381.47 Million TWD	6.43%
2020 Q3	308.42 Million TWD	-19.15%
2020 Q4	226 Million TWD	-26.72%
2020 Q1	358.41 Million TWD	109.86%
2019 Q1	265.31 Million TWD	55.16%
2019 Q4	170.78 Million TWD	-32.87%
2019 FY	935.77 Million TWD	24.95%
2019 Q3	254.43 Million TWD	3.75%
2019 Q2	245.23 Million TWD	-7.57%
2018 Q3	211.58 Million TWD	-9.82%
2018 FY	748.94 Million TWD	89.28%
2018 Q4	170.99 Million TWD	-19.18%
2018 Q2	234.62 Million TWD	78.1%
2018 Q1	131.73 Million TWD	19.28%
2017 Q4	110.44 Million TWD	12.6%
2017 FY	395.68 Million TWD	-49.95%
2017 Q1	100.82 Million TWD	20.16%
2017 Q2	86.33 Million TWD	-14.37%
2017 Q3	98.08 Million TWD	13.61%
2016 Q1	292.17 Million TWD	142.34%
2016 Q3	188.8 Million TWD	-16.32%
2016 Q4	83.9 Million TWD	-55.56%
2016 FY	790.52 Million TWD	20.68%
2016 Q2	225.63 Million TWD	-22.78%
2015 Q1	169.62 Million TWD	64.53%
2015 Q2	218.98 Million TWD	29.1%
2015 FY	655.05 Million TWD	36.65%
2015 Q3	145.88 Million TWD	-33.38%
2015 Q4	120.56 Million TWD	-17.35%
2014 Q2	127.74 Million TWD	-2.15%
2014 Q4	103.09 Million TWD	-12.6%
2014 FY	479.35 Million TWD	20.75%
2014 Q1	130.55 Million TWD	42.89%
2014 Q3	117.96 Million TWD	-7.66%
2013 FY	396.98 Million TWD	-0.23%
2013 Q3	104.48 Million TWD	8.08%
2013 Q4	91.36 Million TWD	-12.56%
2013 Q2	96.67 Million TWD	-7.44%
2013 Q1	104.44 Million TWD	-4.94%
2012 Q2	76.82 Million TWD	-32.55%
2012 Q1	113.88 Million TWD	54.8%
2012 Q4	109.87 Million TWD	12.92%
2012 Q3	97.3 Million TWD	26.66%
2012 FY	397.88 Million TWD	29.53%
2011 Q3	68.63 Million TWD	-6.53%
2011 Q1	91.55 Million TWD	-0.89%
2011 Q2	73.43 Million TWD	-19.79%
2011 FY	307.18 Million TWD	-6.62%
2011 Q4	73.57 Million TWD	7.19%
2010 FY	328.95 Million TWD	-0.73%
2010 Q2	86.2 Million TWD	14.66%
2010 Q1	75.18 Million TWD	0.0%
2010 Q4	92.37 Million TWD	22.85%
2010 Q3	75.19 Million TWD	-12.78%
2009 FY	331.37 Million TWD	0.0%

Peer Gross Profit Comparison of SCI Pharmtech, Inc.

Name	Gross Profit	Gross Profit Difference
Grape King Bio Ltd	8.53 Billion TWD	95.895%
Standard Chem & Pharm CO., LTD.	2.72 Billion TWD	87.146%
Maywufa Company Ltd.	854.37 Million TWD	58.996%
ScinoPharm Taiwan, Ltd.	1.21 Billion TWD	71.19%
Lotus Pharmaceutical Co., Ltd.	8.33 Billion TWD	95.799%
LIWANLI Innovation Co., Ltd.	15.08 Million TWD	-2222.635%
YungShin Global Holding Corporation	2.91 Billion TWD	87.966%
PhytoHealth Corporation	67.64 Million TWD	-417.9%
Formosa Laboratories, Inc.	1.9 Billion TWD	81.594%
PharmaEssentia Corporation	4.49 Billion TWD	92.207%
Bora Pharmaceuticals Co., LTD.	6.99 Billion TWD	94.989%

Global Stocks Search

SCI Pharmtech, Inc. (4119.TW)

Gross Profit Summary of SCI Pharmtech, Inc.

Annual Gross Profit Chart of SCI Pharmtech, Inc. (2023 - 2009)

Historical Annual Gross Profit of SCI Pharmtech, Inc. (2023 - 2009)

Peer Gross Profit Comparison of SCI Pharmtech, Inc.